The Role of Dopamine in the Stimulant Characteristics of Novel Psychoactive Substances (NPS)-Neurobiological and Computational Assessment Using the Case of Desoxypipradrol (2-DPMP)

Frontiers in Pharmacology
Barbara LoiJolanta Opacka-Juffry

Abstract

Stimulant drugs, including novel psychoactive substances (NPS, formerly "legal highs") have addictive potential which their users may not realize. Stimulants increase extracellular dopamine levels in the brain, including the reward and addiction pathways, through interacting with dopamine transporter (DAT). This work aimed to assess the molecular and atomistic mechanisms of stimulant NPS actions at DAT, which translate into biological outcomes such as dopamine release in the brain's reward pathway. We applied combined in vitro, in vivo, and in silico methods and selected 2-diphenylmethylpiperidine (2-DPMP) as an example of stimulant NPS for this study. We measured in vitro binding of 2-DPMP to rat striatum and accumbens DAT by means of quantitative autoradiography with a selective DAT-radioligand [125I]RTI-121. We evaluated the effects of intravenously administered 2-DPMP on extracellular dopamine in the accumbens-shell and striatum using in vivo microdialysis in freely moving rats. We used dynamic modeling to investigate the interactions of 2-DPMP within DAT, in comparison with cocaine and amphetamine. 2-DPMP potently displaced the radioligand in the accumbens and striatum showing dose-dependence from 0.3 to 30 μM. IC50 values...Continue Reading

References

Jul 1, 1991·Trends in Neurosciences·M J KuharJ W Boja
Mar 1, 1990·Trends in Pharmacological Sciences·G Di Chiara
Feb 1, 1988·Journal of Neurochemistry·S P ButcherG W Arbuthnott
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·G Di Chiara, A Imperato
Dec 19, 1995·Proceedings of the National Academy of Sciences of the United States of America·F E PontieriG Di Chiara
Feb 1, 1996·Journal of Molecular Graphics·W HumphreyK Schulten
Oct 7, 2004·Neuropharmacology·Gaetano Di ChiaraDaniele Lecca
Oct 14, 2005·Journal of Computational Chemistry·James C PhillipsKlaus Schulten
Jan 27, 2007·The Journal of Biological Chemistry·Roxanne A VaughanAmy Hauck-Newman
Nov 14, 2007·Archives of Neurology·Nora D VolkowFrank Telang
Jun 24, 2008·Nature Neuroscience·Thijs BeumingClaus J Loland
Aug 14, 2008·The British Journal of Psychiatry : the Journal of Mental Science·Mark R C DaglishDavid J Nutt
Mar 25, 2009·Proceedings of the National Academy of Sciences of the United States of America·Matthias QuickJonathan A Javitch
Sep 8, 2010·Neuropharmacology·Heidi BisgaardUlrik Gether
Dec 14, 2011·Journal of Psychopharmacology·Colin Davidson, John Ramsey
Jan 18, 2012·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Simon Gibbons
May 9, 2012·Toxicology Letters·M Coppola, R Mondola
Dec 25, 2012·European Journal of Pharmacology·Les IversenBryan L Roth
Aug 24, 2013·Trends in Pharmacological Sciences·Roxanne A Vaughan, James D Foster
Sep 10, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Patrick DawsonColin Davidson
Jan 25, 2014·Neuropharmacology·Leslie IversenRic Treble
Feb 4, 2014·Biochemical Pharmacology·Linda D SimmlerMatthias E Liechti
May 6, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·Jolanta Opacka-JuffryColin Davidson
Jun 10, 2014·The Journal of Clinical Investigation·Freja H HansenUlrik Gether
Jun 29, 2014·Pharmacological Reviews·S Stevens Negus, Laurence L Miller
Apr 16, 2015·Nature Reviews. Neuroscience·David J NuttPaul R A Stokes
Jun 9, 2009·Journal of Chemical Theory and Computation·M J HarveyG De Fabritiis
Mar 8, 2016·Journal of Chemical Theory and Computation·Stefan DoerrGianni De Fabritiis
Nov 29, 2016·Progress in Neuro-psychopharmacology & Biological Psychiatry·Michelle A SahaiJolanta Opacka-Juffry
Dec 12, 2017·European Journal of Pharmacology·Dino LuethiMatthias E Liechti
Jun 28, 2018·Addiction Biology·Maria A De LucaGaetano Di Chiara
Jul 5, 2019·Nature Structural & Molecular Biology·Mary Hongying Cheng, Ivet Bahar

❮ Previous
Next ❯

Citations

Jul 3, 2021·International Journal of Molecular Sciences·Valeria SogosM Paola Castelli

❮ Previous
Next ❯

Methods Mentioned

BETA
in silico

Software Mentioned

Schrödinger
VMD
Statistica
Acellera
NAMD
ACEMD
[UNK]
ARCHER
LigPrep
GPUS

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.